Charles J. Link Jr., M.D.,
Chairman of the Board, Chief Executive Officer, Chief Scientific Officer
Nicholas N. Vahanian M.D.,
President, Chief Medical Officer
Gordon H. Link Jr., ;
Chief Financial Officer
Thomas A. Raffin M.D.,
Lead Independent Director
Lota S. Zoth CPA ,
Director
Sarah Alexander M.D.,
Independent Director
Paul R. Edick ,
Independent Director
David J. Lundquist, ;
Independent Director
NewLink Genetics Corporation operates as a biopharmaceutical company. The Company, based in the United States, is focused on discovering, developing, and commercializing immunotherapeutic products to improve cancer treatment options for patients and physicians. Its HyperAcute cancer immunotherapies aim to treat